Pura Vida Investments’s Ocera Therapeutics, Inc. OCRX Stock Holding History

Pura Vida Investments’s Portfolio OCRX Stock Details OCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-258,893	Closed	-$544K	–	104
2016 Q4	$544K	Buy	258,893 +9,931	+4%	+$23.2K	0.2%	60
2016 Q3	$657K	Buy	248,962 +117,962	+90%	+$295K	0.2%	78
2016 Q2	$249K	Hold	131,000	–	–	0.11%	71
2016 Q1	$385K	Hold	131,000	–	–	0.18%	72
2015 Q4	$409K	Hold	131,000	–	–	0.17%	67
2015 Q3	$414K	Buy	131,000 +13,581	+12%	+$52.3K	0.24%	56
2015 Q2	$460K	Buy	117,419 +42,419	+57%	+$163K	0.24%	62
2015 Q1	$353K	Hold	75,000	–	–	0.18%	58
2014 Q4	$478K	Buy	+75,000	New	+$439K	0.18%	66

Other funds holding OCRX

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

VMI

VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Hikari Power Tokyo, Japan $855M AUM 14.24% 1-Year Est. Return

ECM

Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 19.31% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Pura Vida Investments's OCRX Position: Q1 2017 in Review

Pura Vida Investments sold out of Ocera Therapeutics, Inc. (OCRX) in Q1 2017, closing a stake of 258,893 shares — an estimated $544K sold.

Pura Vida Investments first reported a position in OCRX in Q4 2014 and held it in 9 quarters. The position peaked at $657K in Q3 2016. 26 funds tracked by Wall St. Rank hold OCRX as of Q1 2017.

Pura Vida Investments reported no remaining Ocera Therapeutics, Inc. position as of Q1 2017 after selling out during the quarter.
Pura Vida Investments sold 258,893 Ocera Therapeutics, Inc. shares in Q1 2017, an estimated $544K.
Pura Vida Investments first reported a position in Ocera Therapeutics, Inc. in Q4 2014 and held it in 9 quarters.
Pura Vida Investments's Ocera Therapeutics, Inc. position peaked at $657K in Q3 2016.
26 funds tracked by Wall St. Rank held Ocera Therapeutics, Inc. as of Q1 2017.

Based on Pura Vida Investments's 13F filing for Q1 2017, filed 15 May 2017.